chitosan has been researched along with Pseudomonas Infections in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 8 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, D; Arunachalam, K; Balusamy, SR; Gurusamy, A; Kathirason, SG; Sellami, H; Shanmugam, R; Subramaniam, R | 1 |
| Boková, S; Kašparová, P; Lokočová, K; Masák, J; Maťátková, O; Michailidu, J; Paldrychová, M; Rollová, M; Vaňková, E | 1 |
| Bailey, EJ; Kurata, WE; Moon, AY; Pierce, LM; Polanco, JA | 1 |
| Huang, J; Wu, Y; Ying, Y | 1 |
| Grisoli, P; Guerini, M; Pane, C; Perugini, P | 1 |
| Hadinoto, K; Tran, TT | 1 |
| Liu, L; Liu, Y; Song, X; Wu, X; Yuan, J | 1 |
| Anufrikov, YA; Demyanova, EV; Dubashynskaya, NV; Dubrovskii, YA; Poshina, DN; Raik, SV; Shasherina, AY; Shcherbakova, ES; Skorik, YA | 1 |
| Christy, RJ; Davis, SC; Gil, J; Harding, A; Li, J; Natesan, S; Solis, M; Valdes, J | 1 |
| Banu, SF; Gowrishankar, S; Hari, BNV; Nithyanand, P; Pandian, SK; Rubini, D; Subramani, P; Wilson, A | 1 |
| Agrawal, AK; Anjum, MM; Gade, S; Pandey, N; Patel, KK; Singh, S; Tilak, R; Tripathi, M | 1 |
| Agrawal, AK; Anjum, MM; Muthu, MS; Patel, KK; Singh, S; Surekha, DB; Tilak, R; Tripathi, M | 1 |
| Borden, E; Boyapati, SP; Gadde, M; Kandimalla, KK; Lebby, K; Mulpuru, M; Omtri, RS; Smith, M | 1 |
| Bae, MS; Heo, DN; Kim, EC; Kim, JE; Ko, WK; Kwon, IK; Lee, CH; Lee, DH; Lee, JB; Lee, SJ; Moon, JH; Park, SW | 1 |
| Cui, Z; Feng, X; Gu, J; Han, D; Han, W; Lei, L; Sun, C; Sun, X; Tong, C; Zhang, M | 1 |
| Abdelghany, SM; Deacon, J; Donnelly, RF; Elborn, JS; Gilmore, BF; Jones, DS; Kissenpfennig, A; Megaw, J; Quinn, DJ; Schmid, D; Scott, CJ; Taggart, CC | 1 |
| Cardoso, O; Gaspar, MC; Murtinho, D; Olivier, JC; Pais, AA; Serra, ME; Sousa, JJ; Tewes, F | 1 |
| Liu, TM; Qiu, YR; Wu, XZ | 1 |
| Emami, A; Karimi, G; Khorram, M; Lahooti, B; Mohammadi, A | 1 |
| Elmaradny, HA; Mehanna, MM; Samaha, MW | 1 |
| Haggard, WO; Noel, SP; Stinner, DJ; Watson, JT; Wenke, JC | 1 |
| Aziz, MA; Brooks, HJ; Cabral, JD; Hanton, LR; Moratti, SC | 1 |
| Kobayashi, M; Okawa, Y; Suzuki, M; Suzuki, S | 1 |
| Khor, E; Lau, SK; Loke, WK; Sum, CK; Yong, LL | 1 |
24 other study(ies) available for chitosan and Pseudomonas Infections
| Article | Year |
|---|---|
Curcumin-Chitosan Nanocomposite Formulation Containing
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biocompatible Materials; Cell Line, Tumor; Chitosan; Curcumin; Humans; Metal Nanoparticles; Millettia; Nanocomposites; Nanotechnology; Particle Size; Plant Extracts; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Staphylococcal Infections; Staphylococcus aureus; Wound Healing | 2021 |
Addition time plays a major role in the inhibitory effect of chitosan on the production of Pseudomonas aeruginosa virulence factors.
Topics: Anti-Bacterial Agents; Biofilms; Chitosan; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2022 |
Antibacterial Efficacy of a Chitosan-Based Hydrogel Modified With Epsilon-Poly-l-Lysine Against Pseudomonas aeruginosa in a Murine-Infected Burn Wound Model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Peptides; Burns; Chitosan; Humans; Hydrogels; Mice; Polylysine; Pseudomonas aeruginosa; Pseudomonas Infections; Swine; Wound Infection | 2023 |
Preparation and characterization of chitosan/poly(vinyl alcohol)/graphene oxide films and studies on their antibiofilm formation activity.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Biofilms; Chitosan; Graphite; Humans; Polyvinyl Alcohol; Pseudomonas aeruginosa; Pseudomonas Infections | 2020 |
Microstructured Lipid Carriers (MLC) Based on N-Acetylcysteine and Chitosan Preventing
Topics: Acetylcysteine; Anti-Infective Agents; Biofilms; Chitosan; Drug Delivery Systems; Drug Liberation; Lipids; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |
A Potential Quorum-Sensing Inhibitor for Bronchiectasis Therapy: Quercetin-Chitosan Nanoparticle Complex Exhibiting Superior Inhibition of Biofilm Formation and Swimming Motility of
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Biofilms; Bronchiectasis; Chemical Phenomena; Chitosan; Drug Carriers; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Molecular Structure; Nanoparticles; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Quercetin; Quorum Sensing; Solubility; Spectrum Analysis | 2021 |
Chitosan-Based Functional Films Integrated with Magnolol: Characterization, Antioxidant and Antimicrobial Activity and Pork Preservation.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biphenyl Compounds; Chitosan; Food Packaging; Food Preservation; Lignans; Pork Meat; Pseudomonas aeruginosa; Pseudomonas Infections; Swine | 2021 |
Hyaluronan/Diethylaminoethyl Chitosan Polyelectrolyte Complexes as Carriers for Improved Colistin Delivery.
Topics: Anti-Bacterial Agents; Chitosan; Colistin; Drug Carriers; Humans; Hyaluronic Acid; Polyelectrolytes; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |
A PEGylated fibrin hydrogel-based antimicrobial wound dressing controls infection without impeding wound healing.
Topics: Animals; Anti-Infective Agents, Local; Bandages, Hydrocolloid; Chitosan; Disease Models, Animal; Fibrin; Microspheres; Pseudomonas Infections; Silver Sulfadiazine; Swine; Wound Healing; Wounds and Injuries | 2017 |
Extracted chitosan disrupts quorum sensing mediated virulence factors in Urinary tract infection causing pathogens.
Topics: Anti-Bacterial Agents; Biofilms; Chitosan; Fluorescent Antibody Technique; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Urinary Tract Infections; Virulence Factors | 2019 |
Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chitosan; Ciprofloxacin; Cystic Fibrosis; Drug Liberation; Enzymes, Immobilized; Erythrocytes; Hemolysis; Humans; Lung; Male; Nanoparticles; Platelet Aggregation; Polysaccharide-Lyases; Pseudomonas aeruginosa; Pseudomonas Infections; Rats, Wistar | 2019 |
Antibiofilm Potential of Silver Sulfadiazine-Loaded Nanoparticle Formulations: A Study on the Effect of DNase-I on Microbial Biofilm and Wound Healing Activity.
Topics: Animals; Biofilms; Cell Survival; Cells, Cultured; Chitosan; Deoxyribonuclease I; Drug Compounding; Drug Delivery Systems; Excipients; Fibroblasts; Humans; Male; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Silver Sulfadiazine; Skin; Treatment Outcome; Wound Healing; Wound Infection | 2019 |
Ability of chitosan gels to disrupt bacterial biofilms and their applications in the treatment of bacterial vaginosis.
Topics: Acrylic Resins; Adhesives; Biofilms; Chitosan; Female; Gels; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Vaginosis, Bacterial | 2013 |
Electrospun chitosan nanofibers with controlled levels of silver nanoparticles. Preparation, characterization and antibacterial activity.
Topics: Anti-Bacterial Agents; Bandages; Chitosan; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Nanofibers; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
Topics: Administration, Intranasal; Animals; Antibodies, Bacterial; Antibody Formation; Bacterial Proteins; Base Sequence; Cell Line; Chitosan; Female; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin G; Interferon-gamma; Interleukin-4; Lipoproteins; Macrophages; Mannose; Mice; Mice, Inbred BALB C; Microspheres; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas Vaccines; Recombinant Proteins; T-Lymphocytes | 2015 |
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
Topics: Adult; Alginates; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Chitosan; Cystic Fibrosis; Deoxyribonuclease I; DNA; Glucuronic Acid; Hexuronic Acids; Humans; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sputum; Tobramycin; Treatment Outcome | 2015 |
Optimization of levofloxacin-loaded crosslinked chitosan microspheres for inhaled aerosol therapy.
Topics: Anti-Bacterial Agents; Chitosan; Cross-Linking Reagents; Cystic Fibrosis; Drug Carriers; Drug Liberation; Humans; Levofloxacin; Microspheres; Particle Size; Powder Diffraction; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Therapy; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical | 2015 |
Enhanced biocompatibility and antibacterial property of polyurethane materials modified with citric acid and chitosan.
Topics: Adult; Anti-Bacterial Agents; Biocompatible Materials; Blood Coagulation; Blood Platelets; Chitosan; Citric Acid; Hemolysis; Humans; Materials Testing; Platelet Adhesiveness; Polyurethanes; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Modeling and optimization of antibacterial activity of the chitosan-based hydrogel films using central composite design.
Topics: Anti-Bacterial Agents; Bandages; Chitosan; Gelatin; Honey; Humans; Hydrogels; Polyvinyl Alcohol; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Thymus Plant; Wound Healing | 2016 |
Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
Topics: Adhesiveness; Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Delivery Systems; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Liposomes; Male; Microbial Sensitivity Tests; Molecular Weight; Permeability; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Rheology; Time Factors | 2010 |
Local antibiotic delivery using tailorable chitosan sponges: the future of infection control?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Biocompatible Materials; Chitosan; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Fractures, Open; Goats; Infection Control; Pseudomonas Infections; Staphylococcal Infections; Vancomycin | 2010 |
Antimicrobial properties of a chitosan dextran-based hydrogel for surgical use.
Topics: Aldehydes; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Cell Wall; Chitosan; Dextrans; Endoscopy; Escherichia coli; Escherichia coli Infections; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Membrane Proteins; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 2012 |
Comparative study of protective effects of chitin, chitosan, and N-acetyl chitohexaose against Pseudomonas aeruginosa and Listeria monocytogenes infections in mice.
Topics: Adjuvants, Immunologic; Animals; Ascitic Fluid; Chitin; Chitosan; Disease Models, Animal; Exudates and Transudates; Injections, Intraperitoneal; Listeria monocytogenes; Listeriosis; Mice; Mice, Inbred Strains; Oligosaccharides; Peroxidase; Pseudomonas aeruginosa; Pseudomonas Infections | 2003 |
Wound dressing with sustained anti-microbial capability.
Topics: Anti-Infective Agents; Bandages; Biocompatible Materials; Burns, Chemical; Chitin; Chitosan; Delayed-Action Preparations; Humans; Hydrogels; In Vitro Techniques; Materials Testing; Microbial Sensitivity Tests; Mustard Compounds; Pseudomonas Infections; Staphylococcal Infections; Water; Wound Infection | 2000 |